Earnings calendar

BioMarin Pharmaceutical Inc. (BMRN) earnings: date, estimates, results and stock reactions

Over the last 12 reports the stock moved 4.5% on average (either way), rising 5 times and falling 7. EPS beat estimates 7 of 11 times; revenue 10 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q4 FY20262026-11-020.23-0.05n/a1.02B1.02B-4.9%
Q3 FY20262026-08-061.200.95+26.7%989.7M932.0M+6.5%
Q2 FY20262026-05-040.760.78-2.6%766.0M752.5M-1.5%
Q1 FY20262026-02-23-0.240.17-241.7%874.6M833.7M-2.3%
Q4 FY20252025-10-27-0.16-0.15-6.7%776.1M777.5M-1.8%
Q3 FY20252025-08-041.230.86+42.9%825.0M761.9M+6.5%
Q2 FY20252025-05-010.970.71+35.9%745.1M738.7M-2.6%
Q1 FY20252025-02-190.640.54+18.5%747.0M712.3M+6.0%

BMRN stock report · Earnings calendar